Goiter Frequency Is More Strongly Associated with Gastric Adenocarcinoma than Urine Iodine Level |
Tabaeizadeh, Mohammad
(Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Endocrinology and Metabolism Research Institute)
Haghpanah, Vahid (Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Endocrinology and Metabolism Research Institute) Keshtkar, Abbasali (Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences) Semnani, Shahryar (Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences) Roshandel, Gholamreza (Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences) Adabi, Khadijeh (Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Endocrinology and Metabolism Research Institute) Heshmat, Ramin (Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences) Rohani, Davood (Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences) Kia, Alireza (Department of Radiology, Golestan University of Medical Sciences) Hatami, Ehsan (Department of Oncology, Golestan University of Medical Sciences) Jahangirrad, Ataollah (Department of Oncology, Golestan University of Medical Sciences) Nabizadeh, Ramin (Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences) Larijani, Bagher (Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Endocrinology and Metabolism Research Institute) |
1 | Kurtz RC, Sherlock P. The diagnosis of gastric cancer. Semin Oncol 1985;12:11-18. |
2 | Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-1452. DOI ScienceOn |
3 | Abnet CC, Fan JH, Kamangar F, Sun XD, Taylor PR, Ren JS, et al. Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. Int J Cancer 2006;119:1508- 1510. DOI ScienceOn |
4 | Venturi S, Venturi A, Cimini D, Arduini C, Venturi M, Guidi A. A new hypothesis: iodine and gastric cancer. Eur J Cancer Prev 1993;2:17-23. |
5 | Venturi S, Grossi L, Marra GA, Venturi A, Venturi M. Iodine, Helicobacter pylori , stomach cancer and evolution. European EPI-Marker 2003;7:1-7. |
6 | Gołkowski F, Szybiński Z, Rachtan J, Sokołowski A, Buziak- Bereza M, Trofimiuk M, et al. Iodine prophylaxis--the protective factor against stomach cancer in iodine deficient areas. Eur J Nutr 2007;46:251-256. DOI |
7 | Gulaboglu M, Yildiz L, Celebi F, Gul M, Peker K. Comparison of iodine contents in gastric cancer and surrounding normal tissues. Clin Chem Lab Med 2005;43:581-584. |
8 | Aceves C, Anguiano B, Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol Neoplasia 2005;10:189-196. DOI |
9 | Kandemir EG, Yonem A, Narin Y. Gastric carcinoma and thyroid status. J Int Med Res 2005;33:222-227. DOI |
10 | Syrigos KN, Konstantoulakis MM, Constantoulakis M, Marafelia P, Koutras D, Golematis BC. Thyroid autoantibodies and thyroid function in patients with gastric cancer. Acta Oncol 1994;33:905-907. DOI |
11 | Behrouzian R, Aghdami N. Urinary iodine/creatinine ratio in patients with stomach cancer in Urmia, Islamic Republic of Iran. East Mediterr Health J 2004;10:921-924. |
12 | Venturi S. Letter to the editor. The thyroid gland. Clin Exp 1998;1:23. |
13 | Banerjee RK, Bose AK, Chakraborty TK, De SK, Datta AG. Peroxidase-catalysed iodotyrosine formation in dispersed cells of mouse extrathyroidal tissues. J Endocrinol 1985;106:159- DOI ScienceOn |
14 | Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996;379:458-460. DOI ScienceOn |
15 | Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, et al. Cloning of the human sodium lodide symporter. Biochem Biophys Res Commun 1996;226:339-345. DOI ScienceOn |
16 | Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000;6:871-878. DOI ScienceOn |
17 | Promotion of iodized salt in the eastern Mediterranean, middleeast and north Africa, report of an inter country meeting, Dubai- United Arab Emirates 10-12 April 2000-WHO. |
18 | Solbiati L, Charboneau JW, James EM, Hay ID. The thyroid gland. In: Rumack CM, Wilson SR, Charboneau JW, eds. Diagnostic Ultrasound. St. Louis: Mosby, 1998:704-705. |
19 | Rossi M, Negri E, Foschi R, Franceschi S, La Vecchia C. Relation between goiter and autoimmune thyroid disease, and gastric cancer. Int J Cancer 2007;120:951-952. DOI ScienceOn |
20 | Anderson M, Takkouche B, Egli I, Allen HE, de Benoist B. Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bulletin of the World Health Organization 2005;83:518-525. |
21 | World Health Organization, United Nations Children's Fund, International Council for Control of Iodine Deficiency Disorders. Assessment of the iodine deficiency disorders and monitoring their elimination. 2nd ed. Geneva: World Health Organization. WHO document WHO/NHD/01.1, 2001. |
22 | Gaitan E. Goitrogens in food and water. Annu Rev Nutr 1990;10:21-39. DOI ScienceOn |
23 | Jameson JL, Weetman AP. Disorders of the thyroid gland. In: Kasper DL, Braunwald E, Fauci AS, eds. Harrison's Principles. Internal Medicine. 16th ed. New York: McGraw-Hill, 2005:2119. |
24 | Beletskaia OM. The pathophysiological significance of the low triiodothyronine syndrome with increased clearance in cancer of the stomach and large intestine. Lik Sprava 1996;(3-4):181-184. |
25 | Guernsey DL, Leuthauser SW. Correlation of thyroid hormone dose-dependent regulation of K-ras protooncogene expression with oncogene activation by 3-methylcholanthrene: loss of thyroidal regulation in the transformed mouse cell. Cancer Res 1987;47:3052-3056. |